FDA Inspection 815738 — Ibrahim Hanna, MD
The FDA completed an inspection of Ibrahim Hanna, MD on Jan 18, 2013 in Birmingham, AL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 18, 2013
- Fiscal Year
- 2013
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Birmingham, AL (United States)
Additional Details
Clinical Investigator (CI)